Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease

Marian A. Del Rosario, Joseph F. Fitzgerald, Sonny K. Chong, Joseph Croffie, Sandeep Gupta

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: The finding of characteristic small intestinal mucosal abnormalities on histologic examination of a biopsy specimen remains the first requirement for the diagnosis of celiac disease. A reliable and noninvasive test would be ideal for the patient's convenience and for reducing health-care costs. The sensitivity and specificity of anti-gliadin antibodies (AGA-immunoglobulin [Ig] G, AGA-IgA) have been variable; anti- endomysium IgA (EmA-IgA) is more helpful. In an earlier study conducted at the authors' institution, celiac disease was present in 19 patients examined from 1992 to 1995. Anti-endomysium titers were higher than normal in all 19 patients (100%). Total villous atrophy was seen in 14 of 17 biopsy specimens (82%) and subtotal atrophy in 3 (18%). The purpose of the current study was to evaluate further the accuracy of EmA-IgA in diagnosing celiac disease. Methods: One hundred seven patients were screened for celiac disease between March 1996 and July 1997. The level of EmA-IgA was measured in all patients, and AGA-IgG and AGA-IgA were measured in 104 patients. Forty-six patients underwent endoscopic biopsy of the small bowel, with measurement of disaccharidase enzymes in 45 patients. Results: Five of 46 patients had celiac disease (three boys and two girls; mean age, 5.3 years; 2-9.5 years); one also had cystic fibrosis and another had insulin-dependent diabetes mellitus. All five had marked to complete villous atrophy with crypt hyperplasia and increased serum EmA-IgA (100% sensitivity). None of the remaining patients had increased EmA-IgA (100% specificity). Serum levels of AGA-IgG and AGA-IgA were increased in all four celiac disease patients (100% sensitivity), but they were also high in patients without celiac disease (38% and 92% specificity, respectively), which compromises their diagnostic value. None of the patients confirmed to have celiac disease had IgA deficiency. Abnormal disaccharidase enzyme activities were documented in all five celiac disease patients: severe generalized deficiency (n = 2), moderately severe generalized deficiency (n = 2), and alactasia with moderate deficiency of the α-glucosidases (n = 1). Conclusions: This study confirmed the reliability and accuracy of EmA-IgA in the diagnosis of celiac disease. Small bowel biopsy may be unnecessary in EmA-positive patients in whom celiac disease is suspected.

Original languageEnglish
Pages (from-to)191-195
Number of pages5
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume27
Issue number2
DOIs
StatePublished - Aug 1998

Fingerprint

Gliadin
celiac disease
gliadin
Celiac Disease
Anti-Idiotypic Antibodies
antibodies
Immunoglobulin A
biopsy
atrophy
Disaccharidases
Atrophy
Biopsy
Immunoglobulin G
IgA Deficiency
Lactose Intolerance
Glucosidases
health care costs
glucosidases
insulin-dependent diabetes mellitus
cystic fibrosis

Keywords

  • Anti-endomysium antibody
  • Anti-gliadin antibodies
  • Biopsy
  • Celiac disease
  • Small intestine

ASJC Scopus subject areas

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease. / Del Rosario, Marian A.; Fitzgerald, Joseph F.; Chong, Sonny K.; Croffie, Joseph; Gupta, Sandeep.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 27, No. 2, 08.1998, p. 191-195.

Research output: Contribution to journalArticle

@article{9dc827dec25245ac97059b4cc71bffad,
title = "Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease",
abstract = "Background: The finding of characteristic small intestinal mucosal abnormalities on histologic examination of a biopsy specimen remains the first requirement for the diagnosis of celiac disease. A reliable and noninvasive test would be ideal for the patient's convenience and for reducing health-care costs. The sensitivity and specificity of anti-gliadin antibodies (AGA-immunoglobulin [Ig] G, AGA-IgA) have been variable; anti- endomysium IgA (EmA-IgA) is more helpful. In an earlier study conducted at the authors' institution, celiac disease was present in 19 patients examined from 1992 to 1995. Anti-endomysium titers were higher than normal in all 19 patients (100{\%}). Total villous atrophy was seen in 14 of 17 biopsy specimens (82{\%}) and subtotal atrophy in 3 (18{\%}). The purpose of the current study was to evaluate further the accuracy of EmA-IgA in diagnosing celiac disease. Methods: One hundred seven patients were screened for celiac disease between March 1996 and July 1997. The level of EmA-IgA was measured in all patients, and AGA-IgG and AGA-IgA were measured in 104 patients. Forty-six patients underwent endoscopic biopsy of the small bowel, with measurement of disaccharidase enzymes in 45 patients. Results: Five of 46 patients had celiac disease (three boys and two girls; mean age, 5.3 years; 2-9.5 years); one also had cystic fibrosis and another had insulin-dependent diabetes mellitus. All five had marked to complete villous atrophy with crypt hyperplasia and increased serum EmA-IgA (100{\%} sensitivity). None of the remaining patients had increased EmA-IgA (100{\%} specificity). Serum levels of AGA-IgG and AGA-IgA were increased in all four celiac disease patients (100{\%} sensitivity), but they were also high in patients without celiac disease (38{\%} and 92{\%} specificity, respectively), which compromises their diagnostic value. None of the patients confirmed to have celiac disease had IgA deficiency. Abnormal disaccharidase enzyme activities were documented in all five celiac disease patients: severe generalized deficiency (n = 2), moderately severe generalized deficiency (n = 2), and alactasia with moderate deficiency of the α-glucosidases (n = 1). Conclusions: This study confirmed the reliability and accuracy of EmA-IgA in the diagnosis of celiac disease. Small bowel biopsy may be unnecessary in EmA-positive patients in whom celiac disease is suspected.",
keywords = "Anti-endomysium antibody, Anti-gliadin antibodies, Biopsy, Celiac disease, Small intestine",
author = "{Del Rosario}, {Marian A.} and Fitzgerald, {Joseph F.} and Chong, {Sonny K.} and Joseph Croffie and Sandeep Gupta",
year = "1998",
month = "8",
doi = "10.1097/00005176-199808000-00012",
language = "English",
volume = "27",
pages = "191--195",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease

AU - Del Rosario, Marian A.

AU - Fitzgerald, Joseph F.

AU - Chong, Sonny K.

AU - Croffie, Joseph

AU - Gupta, Sandeep

PY - 1998/8

Y1 - 1998/8

N2 - Background: The finding of characteristic small intestinal mucosal abnormalities on histologic examination of a biopsy specimen remains the first requirement for the diagnosis of celiac disease. A reliable and noninvasive test would be ideal for the patient's convenience and for reducing health-care costs. The sensitivity and specificity of anti-gliadin antibodies (AGA-immunoglobulin [Ig] G, AGA-IgA) have been variable; anti- endomysium IgA (EmA-IgA) is more helpful. In an earlier study conducted at the authors' institution, celiac disease was present in 19 patients examined from 1992 to 1995. Anti-endomysium titers were higher than normal in all 19 patients (100%). Total villous atrophy was seen in 14 of 17 biopsy specimens (82%) and subtotal atrophy in 3 (18%). The purpose of the current study was to evaluate further the accuracy of EmA-IgA in diagnosing celiac disease. Methods: One hundred seven patients were screened for celiac disease between March 1996 and July 1997. The level of EmA-IgA was measured in all patients, and AGA-IgG and AGA-IgA were measured in 104 patients. Forty-six patients underwent endoscopic biopsy of the small bowel, with measurement of disaccharidase enzymes in 45 patients. Results: Five of 46 patients had celiac disease (three boys and two girls; mean age, 5.3 years; 2-9.5 years); one also had cystic fibrosis and another had insulin-dependent diabetes mellitus. All five had marked to complete villous atrophy with crypt hyperplasia and increased serum EmA-IgA (100% sensitivity). None of the remaining patients had increased EmA-IgA (100% specificity). Serum levels of AGA-IgG and AGA-IgA were increased in all four celiac disease patients (100% sensitivity), but they were also high in patients without celiac disease (38% and 92% specificity, respectively), which compromises their diagnostic value. None of the patients confirmed to have celiac disease had IgA deficiency. Abnormal disaccharidase enzyme activities were documented in all five celiac disease patients: severe generalized deficiency (n = 2), moderately severe generalized deficiency (n = 2), and alactasia with moderate deficiency of the α-glucosidases (n = 1). Conclusions: This study confirmed the reliability and accuracy of EmA-IgA in the diagnosis of celiac disease. Small bowel biopsy may be unnecessary in EmA-positive patients in whom celiac disease is suspected.

AB - Background: The finding of characteristic small intestinal mucosal abnormalities on histologic examination of a biopsy specimen remains the first requirement for the diagnosis of celiac disease. A reliable and noninvasive test would be ideal for the patient's convenience and for reducing health-care costs. The sensitivity and specificity of anti-gliadin antibodies (AGA-immunoglobulin [Ig] G, AGA-IgA) have been variable; anti- endomysium IgA (EmA-IgA) is more helpful. In an earlier study conducted at the authors' institution, celiac disease was present in 19 patients examined from 1992 to 1995. Anti-endomysium titers were higher than normal in all 19 patients (100%). Total villous atrophy was seen in 14 of 17 biopsy specimens (82%) and subtotal atrophy in 3 (18%). The purpose of the current study was to evaluate further the accuracy of EmA-IgA in diagnosing celiac disease. Methods: One hundred seven patients were screened for celiac disease between March 1996 and July 1997. The level of EmA-IgA was measured in all patients, and AGA-IgG and AGA-IgA were measured in 104 patients. Forty-six patients underwent endoscopic biopsy of the small bowel, with measurement of disaccharidase enzymes in 45 patients. Results: Five of 46 patients had celiac disease (three boys and two girls; mean age, 5.3 years; 2-9.5 years); one also had cystic fibrosis and another had insulin-dependent diabetes mellitus. All five had marked to complete villous atrophy with crypt hyperplasia and increased serum EmA-IgA (100% sensitivity). None of the remaining patients had increased EmA-IgA (100% specificity). Serum levels of AGA-IgG and AGA-IgA were increased in all four celiac disease patients (100% sensitivity), but they were also high in patients without celiac disease (38% and 92% specificity, respectively), which compromises their diagnostic value. None of the patients confirmed to have celiac disease had IgA deficiency. Abnormal disaccharidase enzyme activities were documented in all five celiac disease patients: severe generalized deficiency (n = 2), moderately severe generalized deficiency (n = 2), and alactasia with moderate deficiency of the α-glucosidases (n = 1). Conclusions: This study confirmed the reliability and accuracy of EmA-IgA in the diagnosis of celiac disease. Small bowel biopsy may be unnecessary in EmA-positive patients in whom celiac disease is suspected.

KW - Anti-endomysium antibody

KW - Anti-gliadin antibodies

KW - Biopsy

KW - Celiac disease

KW - Small intestine

UR - http://www.scopus.com/inward/record.url?scp=0031926789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031926789&partnerID=8YFLogxK

U2 - 10.1097/00005176-199808000-00012

DO - 10.1097/00005176-199808000-00012

M3 - Article

VL - 27

SP - 191

EP - 195

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -